Clioquinol

an experimental drug that binds zinc and copper, shown to lower the levels of beta amyloid. A small-scale clinical trial had some success in slowing cognitive decline in patients with moderate-to-severe Alzheimer's.

There is currently no content classified with this term.

Subscribe to RSS - Clioquinol